KATHRYN REINMANN: Open Payments
NPI 1255086864 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,540 in 224 payments from 20 companies in 2025. Trend: 2023 $680 · 2024 $4,181 · 2025 $4,540
Food & beverage: $4,436Education: $104
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $800 |
| ABBVIE INC. | 29 | $622 |
| UCB, Inc. | 31 | $560 |
| Galderma Laboratories, L.P. | 25 | $359 |
| Regeneron Healthcare Solutions, Inc. | 8 | $285 |
| Incyte Corporation | 13 | $270 |
| GENZYME CORPORATION | 7 | $242 |
| Arcutis Biotherapeutics, Inc. | 15 | $198 |
| E.R. Squibb & Sons, L.L.C. | 13 | $189 |
| LEO Pharma Inc. | 7 | $179 |
Products named: TREMFYA, Bimzelx, RINVOQ, DUPIXENT, NEMLUVIO, OPZELURA, Zoryve, Sotyktu.
Industry payments across CT — which companies pay providers there.
